Clinical Trials Directory

Trials / Completed

CompletedNCT04953832

Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Anxiety disorders are highly prevalent and costly to the individual and society. Exposure-based cognitive behavioral therapy (CBT) is the gold-standard intervention for anxiety disorders, although this approach does not fully reduce symptoms for all individuals. Therefore there is a need for innovative intervention approaches. One approach to augment and improve existing therapies would be to enhance the neurocognitive basis of fear extinction processes, which are the model on which treatments are based. Enhancing these processes may be possible through computerized cognitive training techniques which target executive functioning, the cognitive processes that help people manage complex cognitive activities. The proposed project is a proof-of-concept pilot study investigating the potential for training of executive functioning to improve anxiety-related outcomes. Individuals with elevated levels of social anxiety will be randomized to single-session COGnitive Enhancement Training (COGENT) or sham training program (ST). All participants will complete a single speech session where they present three 7-minute impromptu speeches and rate their anxiety at specific intervals. Participants will then complete the COGENT paradigm and affective processing task while undergoing fMRI.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive TrainingParticipants are asked to remember a series of items while solving puzzles.

Timeline

Start date
2019-11-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2021-07-08
Last updated
2021-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04953832. Inclusion in this directory is not an endorsement.